Lifevantage (LFVN) vs Medicinova (MNOV)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Medicinova (MNOV) has outperformed Lifevantage (LFVN) over the past year, gaining 28.8% versus a loss of 35.1%. Over five years, LFVN leads with a -12.0% price change compared with -57.9% for MNOV. Medicinova is the larger company by market cap ($76.3 million vs $76.0 million), about 1.0 times the size.
Lifevantage pays a dividend yielding 3.06%, while Medicinova does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | LFVN | MNOV |
|---|---|---|
| Share price | $6.04 | $1.55 |
| Market cap | $76.04M | $76.29M |
| 1-day change | +0.67% | -3.73% |
| YTD return | -2.60% | +22.90% |
| 1-year return | -35.14% | +28.80% |
| 5-year return | -12.02% | -57.85% |
| P/E ratio (TTM) | 15.10 | — |
| Forward P/E | 15.62 | — |
| EPS (TTM) | $0.40 | $-0.21 |
| Dividend yield | 3.06% | 0.00% |
| Annual dividend | $0.185 | $0.00 |
| 52-week high | $11.71 | $3.90 |
| 52-week low | $3.90 | $1.17 |
| Distance from 52-week high | -48.42% | -60.26% |
| Average volume | 61.18K | 321.31K |
| Shares outstanding | 12.59M | 49.22M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- MNOV has outperformed LFVN by 63.9 percentage points over the past year.
- Lifevantage offers a meaningfully higher dividend yield (3.06% vs 0.00%).
LFVN vs MNOV FAQ
Which is bigger, Lifevantage or Medicinova?
Medicinova (MNOV) is larger, with a market capitalization of $76.29M compared with $76.04M for Lifevantage (LFVN).
Which stock has performed better over the past year, LFVN or MNOV?
MNOV returned +28.80% over the past 12 months, compared with -35.14% for LFVN (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Lifevantage or Medicinova?
Lifevantage pays a dividend yielding 3.06%, while Medicinova does not currently pay a regular dividend.
Are Lifevantage and Medicinova in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.